BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 11745245)

  • 21. Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides.
    Bakels V; van Oostveen JW; Gordijn RL; Walboomers JM; Meijer CJ; Willemze R
    Arch Dermatol; 1992 Dec; 128(12):1602-7. PubMed ID: 1456753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations in Sezary syndrome.
    Iżykowska K; Przybylski GK
    Leuk Lymphoma; 2011 May; 52(5):745-53. PubMed ID: 21323514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sézary Syndrome: Clinical and Biological Aspects.
    Kohnken R; Fabbro S; Hastings J; Porcu P; Mishra A
    Curr Hematol Malig Rep; 2016 Dec; 11(6):468-479. PubMed ID: 27704468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sézary syndrome: diagnosis, prognosis, and critical review of treatment options.
    Wieselthier JS; Koh HK
    J Am Acad Dermatol; 1990 Mar; 22(3):381-401. PubMed ID: 2138177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome.
    Fraser-Andrews EA; Russell-Jones R; Woolford AJ; Wolstencroft RA; Dean AJ; Whittaker SJ
    Cancer; 2001 Oct; 92(7):1745-52. PubMed ID: 11745245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell receptor gene analysis in the diagnosis of Sézary syndrome.
    Russell-Jones R; Whittaker S
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):254-9. PubMed ID: 10426897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic tools in Sezary syndrome.
    Möbs M; Knott M; Fritzen B; Pullmann S; Sterry W; Assaf C
    G Ital Dermatol Venereol; 2010 Jun; 145(3):385-91. PubMed ID: 20461046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
    Nagler AR; Samimi S; Schaffer A; Vittorio CC; Kim EJ; Rook AH
    J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.
    Moerman-Herzog A; Mehdi SJ; Wong HK
    Cells; 2020 Aug; 9(9):. PubMed ID: 32872487
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.